By Brad Sorensen, CFA NASDAQ:MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic cannabinoid analog for the treatment of adult patients with neuropathic pain as well as anxiety and cognitive decline typically associated with early-stage dementia. The company … Read more
By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Interim Data from IIS Study Shows 75% Response Rate and Three Complete Responses On April 14, 2025, Soligenix, Inc. (NASDAQ:SNGX) announced interim data from the ongoing, open label, investigator-initiated study (IIS) of HyBryte (synthetic hypericin) treatment for up to 54 weeks in … Read more
By Brian Lantier, CFA NASDAQ:SUUN READ THE FULL SUUN RESEARCH REPORT SolarBank (NASDAQ:SUUN) is a vertically integrated solar and battery energy storage system (BESS) project developer, engineering, procurement, construction service provider (EPC), and independent power producer (IPP) principally focused on community solar and corporate projects in New York and Ontario. As the company moves into … Read more
NASDAQ:COCP John M. Viglotti: Hello and welcome to Virtual Investor Conferences. On behalf of the Life Sciences Investor Forum and our co-host, Zacks Small Cap Research, we’re very pleased you joined us for our quarterly conference. Our next live presentation is from Cocrystal Pharma. Cocrystal is a clinical-stage biotech company developing novel antiviral therapeutics. Please … Read more
By M. Marin NASDAQ:LGMK READ THE FULL LGMK RESEARCH REPORT Recent introduction of next-gen Guardian Alert 911 Plus in 1Q25… LogicMark, Inc. (NASDAQ:LGMK) launched the next generation of the Guardian Alert 911 Plus in February 2025. The next-generation Guardian Alert 911 Plus expands the company’s product suite and offers an upgrade from the earlier version … Read more